Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients.
Sekhri
Arunabh
A
Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Liu
Delong
D
Rasul
Muhammad
M
Ahmed
Nasir
N
Ahmed
Tauseef
T
Seiter
Karen
K
D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014184:Transplantation, Homologous